Obalon Therapeutics, Inc. Announces Two Agreements To Provide Up To $30 Million of Capital
December 27, 2018 17:53 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces FDA Approval of Obalon Navigation System
December 21, 2018 09:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Key Weight Loss and Safety Data Presented for the Obalon Swallowable Gas-Filled Balloon System at the 35th ASMBS Annual Meeting at Obesity Week 2018
November 15, 2018 09:15 ET
|
Obalon Therapeutics, Inc.
Clinical results presented from over 1,300 patients treated at 108 sites with Obalon’s non-surgical weight loss solution in commercial setting SAN DIEGO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Obalon...
Obalon Balloon System Data to be Featured in Presentation During 35th ASMBS Annual Meeting at Obesity Week 2018
November 07, 2018 09:15 ET
|
Obalon Therapeutics, Inc.
Clinical results from over 1,300 patients at 108 sites treated with Obalon’s novel weight loss device solution in commercial use SAN DIEGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics,...
Obalon Announces Third Quarter 2018 Financial Results
November 02, 2018 08:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
FDA Grants PMA-S Approval for Obalon Touch™ Inflation System
September 26, 2018 09:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon to Host Corporate Strategy Update Call with Investors and Analysts on September 10, 2018
August 29, 2018 09:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Therapeutics to Raise $10 Million in Private Placement
August 23, 2018 09:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN) a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Upcoming Conference Presentation
August 07, 2018 09:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Schedules First Quarter 2018 Financial Results Conference Call for May 10, 2018 at 5:00 p.m. Eastern Time
May 04, 2018 10:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 04, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...